Hong Kong Diabetes Association Releases New Microfilm on Diabetic Kidney Disease
AM730 · 1 SOURCESabout 1 hour ago2 MIN
Summary
The Hong Kong Diabetes Association has released Episode 4 of its "Kidney Beans" microfilm series titled "Dialysis's Dead End" to mark its 30th anniversary. The film dramatizes the story of Brother Keung, a dialysis patient who neglected regular check-ups, to emphasize the critical importance of early detection and treatment of diabetic kidney disease. Medical experts featured in the production stress that timely intervention with appropriate medications can significantly slow disease progression.
Key Points
- The microfilm features actor Tai Yiu-ming portraying Brother Keung, whose eGFR has dropped to 10, requiring dialysis and leaving him breathless after walking a few steps
- Nephrology Professor Yip Yat-hin and respiratory specialist Tso Chung-ho appear as medical advisors in the production
- Approximately one in three type 2 diabetes patients develops diabetic kidney disease, with Hong Kong having over 10,000 end-stage renal failure patients
- About 50% of Hong Kong's dialysis and kidney transplant patients developed their condition due to diabetes
- Early-stage diabetic kidney disease typically presents no obvious symptoms, with signs like swelling, fatigue, and shortness of breath appearing only in moderate to advanced stages
- Treatment with SGLT2 inhibitors and RAAS inhibitors can potentially delay progression to end-stage renal failure by approximately 15 years
- The five-year survival rate for dialysis patients is approximately 40%
- Diabetes affects lung health by damaging pulmonary microvasculature, increasing risks of COPD, pulmonary fibrosis, and pneumonia
Why It Matters
Diabetic kidney disease represents a silent epidemic in Hong Kong, with half of all end-stage renal failure cases stemming from diabetes. The microfilm's message that early intervention through annual eGFR and proteinuria testing can delay dialysis by 15 years offers a crucial window for patients to preserve their quality of life, maintain employment, and remain present for their families.
Diabetic kidney disease represents a silent epidemic in Hong Kong, with half of all end-stage renal failure cases stemming from diabetes. The microfilm's message that early intervention through annual eGFR and proteinuria testing can delay dialysis by 15 years offers a crucial window for patients to preserve their quality of life, maintain employment, and remain present for their families.